Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Clear Scientific

Private
#Overdose Reversal#Addiction Medicine#CNS Disorders

Clinical-stage biopharmaceutical company developing small-molecule sequestrant-based therapies designed to capture and clear harmful substances from the body, with a focus on drug overdose reversal and CNS dysfunction.

Company Info

Sector:Biotechnology
Headquarters:Cambridge, Massachusetts, USA
Founded:2016
Website:www.clearsci.com/

Clinical Development Pipeline

CS-1103

Target: Small-molecule drug sequestrant
Fentanyl and methamphetamine overdose
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Fentanyl/xylazine overdose sequestrant

Target: Small-molecule drug sequestrant
Polysubstance overdose
Preclinical
Phase 1
Phase 2
Phase 3
Approved

CNS-active sequestrant candidates

Target: Small-molecule sequestrant
Neurological and metabolic dysfunction
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Shekar Shetty

Chief Executive Officer

Careers & Job Openings

See all open roles

All
Cambridge, Massachusetts, USA
Apply Now →